Harrow Health

HROW59

$42.86arrow_drop_down17.23%-$8.93

HROW59

$42.86

arrow_drop_down17.23%-$8.93

Performance History

Key Stats
Open	$40.95
Prev. Close	$51.80
EPS	-0.95
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	36.71	42.31
52 Week Range	7.60	54.95

Ratios







EPS	-0.95

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Harrow Health (HROW)

Harrow Health Inc (HROW) is a pharmaceutical company that focuses on acquiring, developing, and commercializing innovative treatments for various medical conditions. With a strong commitment to improving patient outcomes and providing high-quality healthcare solutions, Harrow Health has become a prominent player in the industry. The company's stock price history has shown steady growth over the years, reflecting investor confidence in its business model and product portfolio.

As of the latest quote, Harrow Health Inc (HROW) is trading at $10.50 per share. This demonstrates the company's strong position in the market and its ability to generate value for shareholders. The stock has shown resilience even in uncertain market conditions, indicating the market's trust in Harrow Health's long-term prospects.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Mark L. Baum J.D.
Headquarters: Nashville
Employees: 217
Exchange: NASDAQ

Keep an eye on Harrow Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Harrow Health 's (HROW) price per share?

The current price per share for Harrow Health (HROW) is $42.86. The stock has seen a price change of -$8.93 recently, indicating a -17.24% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Harrow Health (HROW)?

For Harrow Health (HROW), the 52-week high is $54.95, which is 28.22% from the current price. The 52-week low is $7.6, the current price is 463.95% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Harrow Health (HROW) a growth stock?

Harrow Health (HROW) has shown an average price growth of -3.55% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Harrow Health as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Harrow Health (HROW) stock price performance year to date (YTD)?

As of the latest data, Harrow Health (HROW) has a year-to-date price change of 258.66%. Over the past month, the stock has experienced a price change of -15.78%. Over the last three months, the change has been 15.68%. Over the past six months, the figure is 163.92%. Looking at a longer horizon, the five-year price change stands at 654.58%.

help

Is Harrow Health (HROW) a profitable company?

Harrow Health (HROW) has a net income of -$24.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.55% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 3.13% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $130.19M, with a revenue growth rate of 46.95%, providing insight into the company's sales performance and growth. The gross profit is $90.55M. Operating income is noted at $580K. Furthermore, the EBITDA is $12.71M.

help

What is the market capitalization of Harrow Health (HROW)?

Harrow Health (HROW) has a market capitalization of $1.52B. The average daily trading volume is 42.95, indicating the stock's liquidity and investor engagement.